These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18430104)

  • 1. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin.
    Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Mori R; Tomoda K; Hamaguchi M; Ogawa R; Katada T; Harada K; Fujii Y
    Dis Esophagus; 2008; 21(3):230-5. PubMed ID: 18430104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
    Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
    Shen LY; Wang H; Dong B; Yan WP; Lin Y; Shi Q; Chen KN
    Oncotarget; 2016 Jan; 7(4):4531-41. PubMed ID: 26673820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.
    Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells.
    Suchi K; Fujiwara H; Okamura S; Okamura H; Umehara S; Todo M; Furutani A; Yoneda M; Shiozaki A; Kubota T; Ichikawa D; Okamoto K; Otsuji E
    Anticancer Res; 2011 Jan; 31(1):67-75. PubMed ID: 21273582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate genes involved in the radiosensitivity of esophageal cancer cells by microarray analysis.
    Ogawa R; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Mori R; Tomoda K; Katada T; Harada K; Fujii Y
    Dis Esophagus; 2008; 21(4):288-97. PubMed ID: 18477249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells.
    Toshimitsu H; Hashimoto K; Tangoku A; Iizuka N; Yamamoto K; Kawauchi S; Oga A; Furuya T; Oka M; Sasaki K
    Cancer Lett; 2004 Jul; 211(1):69-78. PubMed ID: 15194218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinoma.
    Tsutsui M; Kawakubo H; Hayashida T; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Takeuchi H; Kitagawa Y
    Int J Oncol; 2015 Sep; 47(3):867-74. PubMed ID: 26202837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression changes in a chemoresistant model with human esophageal cancer xenografts using cDNA microarray.
    Yoshida T; Miyoshi T; Seike J; Yamai H; Takechi H; Yuasa Y; Tangoku A
    Anticancer Res; 2009 Apr; 29(4):1163-8. PubMed ID: 19414360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A.
    Li Z; Li S; Wen Y; Chen J; Liu K; Jia J
    Technol Cancer Res Treat; 2021; 20():15330338211039127. PubMed ID: 34747666
    [No Abstract]   [Full Text] [Related]  

  • 12. Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines.
    Lee SK; Kim SB; Kim JS; Moon CH; Han MS; Lee BJ; Chung DK; Min YJ; Park JH; Choi DH; Cho HR; Park SK; Park JW
    Int J Cancer; 2005 Oct; 117(1):32-40. PubMed ID: 15880358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
    Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y
    Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
    Shi S; Huang X; Ma X; Zhu X; Zhang Q
    PLoS One; 2020; 15(5):e0225290. PubMed ID: 32369495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced modification of microRNA expression in esophageal cancer.
    Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of response to preoperative chemoradiation in esophageal cancers.
    Luthra R; Luthra MG; Izzo J; Wu TT; Lopez-Alvarez E; Malhotra U; Choi IS; Zhang L; Ajani JA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S2-5. PubMed ID: 17178277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
    Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
    Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.